BioCentury
ARTICLE | Finance

Poseida brings in $110M ahead of IPO as more biotechs line up for NASDAQ debuts

June 26, 2020 1:47 AM UTC

June has already seen 13 biopharmas raise more than a total of $4.7 billion from NASDAQ IPOs, and biotechs are continuing to line up for public market debuts (see “Biotech IPOs on NASDAQ Maintain Momentum”).

Poseida Therapeutics Inc. and iTeos Therapeutics S.A., are revisiting their IPO plans after snagging mezzanine rounds. Another pair -- Akouos Inc. and Fusion Pharmaceuticals Inc. -- upped their offerings ahead of exits expected tonight, while Relay Therapeutics Inc. joined the IPO queue on Wednesday. ...